Pharma Mar, S.A. (BME:PHM)

Pharma Mar Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	63.24	60.02	149.81	113.35	96.21
Short-Term Investments	91.29	102.54	32.61	88.53	99.31
Cash & Short-Term Investments	154.53	162.56	182.42	201.88	195.52
Cash Growth	-4.94%	-10.89%	-9.64%	3.26%	835.71%
Accounts Receivable	34.27	27.2	29.32	50.91	24.05
Other Receivables	0.41	0.35	-	-	-
Receivables	34.68	27.55	29.32	50.91	24.05
Inventory	50.89	39.29	27.75	10.54	11.93
Prepaid Expenses	1.74	2.92	5.98	3.91	1
Other Current Assets	8.41	20.28	29.71	28	13.15
Total Current Assets	250.25	252.6	275.18	295.23	245.65
Property, Plant & Equipment	57.75	34.54	33.23	26.9	24.75
Long-Term Investments	2.46	6.06	49.4	10.72	20.99
Other Intangible Assets	1	1.23	1.19	1.13	0.99
Long-Term Deferred Tax Assets	36.01	31.47	30.53	27.75	33.42
Long-Term Deferred Charges	-	0.7	1.4	2.11	2.81
Other Long-Term Assets	2.18	13.91	2.33	4.55	1.67
Total Assets	349.64	340.52	393.26	368.39	330.26
Accounts Payable	38.81	29.17	27.49	26.93	21.04
Accrued Expenses	13.57	12.39	10.44	9.5	8.79
Short-Term Debt	4.72	6.46	4.48	3.84	4.77
Current Portion of Long-Term Debt	3.25	6.37	8.64	8.37	10.54
Current Portion of Leases	1.88	1.98	1.61	1.82	1.47
Current Unearned Revenue	5.38	25.93	26.11	30.89	44.71
Other Current Liabilities	15.08	13.59	18.54	4.99	3.61
Total Current Liabilities	82.69	95.89	97.32	86.35	94.92
Long-Term Debt	39.87	27.04	25.88	33.39	37.73
Long-Term Leases	1.36	1.83	2.01	1.92	2.15
Long-Term Unearned Revenue	17.17	22.14	44.9	68.63	92.56
Other Long-Term Liabilities	0.19	0.19	0.19	0.19	0.18
Total Liabilities	141.29	147.08	170.3	190.47	227.54
Common Stock	10.93	11.01	11.01	11.01	11.01
Additional Paid-In Capital	59.86	71.28	71.28	71.28	71.28
Retained Earnings	168.38	142.22	156.51	121.29	41.87
Treasury Stock	-30.83	-31.09	-15.87	-25.68	-21.45
Comprehensive Income & Other	0.02	0.02	0.02	0.02	0.01
Total Common Equity	208.36	193.44	222.96	177.92	102.72
Shareholders' Equity	208.36	193.44	222.96	177.92	102.72
Total Liabilities & Equity	349.64	340.52	393.26	368.39	330.26
Total Debt	51.08	43.67	42.63	49.33	56.67
Net Cash (Debt)	103.45	118.89	139.79	152.55	138.85
Net Cash Growth	-12.99%	-14.95%	-8.36%	9.86%	-
Net Cash Per Share	5.89	6.64	7.74	8.44	7.58
Filing Date Shares Outstanding	17.57	17.64	18.11	18.01	18.11
Total Common Shares Outstanding	17.57	17.64	18.11	18.01	18.11
Working Capital	167.55	156.71	177.86	208.89	150.73
Book Value Per Share	11.86	10.97	12.31	9.88	5.67
Tangible Book Value	207.36	192.2	221.77	176.79	101.74
Tangible Book Value Per Share	11.80	10.90	12.25	9.82	5.62
Land	36.04	29.04	29.04	22.59	21.99
Machinery	60.68	43.28	27.87	24.32	21.51

Updated Mar 7, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.